Description
PRESSCAND PLUS is indicated for the treatment of essential hypertension in adults whose blood pressure is not adequately controlled on candesartan cilexetil or hydrochlorothiazide monotherapy.
Presscand Plus 8/12.5mg
Therapeutic Class: Cardiovascular System
INN: Candesartan Cilexetil+Hydrochlorothiazide
Form:Scored tablet
Presentation:Box of 30
Additional information
| Classe Thérapeutique | |
|---|---|
| Substance active | |
| Forme |
